CARA THERAPEUTICS INC's ticker is CARA and the CUSIP is 140755109. A total of 157 filers reported holding CARA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.47 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $11 | -100.0% | 1,031 | -56.3% | 0.00% | – |
| Q3 2022 | $22,000 | -4.3% | 2,361 | -7.9% | 0.00% | – |
| Q2 2022 | $23,000 | -17.9% | 2,564 | +9.7% | 0.00% | – |
| Q1 2022 | $28,000 | 0.0% | 2,338 | +0.1% | 0.00% | – |
| Q4 2021 | $28,000 | -22.2% | 2,335 | 0.0% | 0.00% | – |
| Q3 2021 | $36,000 | +71.4% | 2,335 | +52.6% | 0.00% | – |
| Q2 2021 | $21,000 | 0.0% | 1,530 | +53.0% | 0.00% | – |
| Q1 2021 | $21,000 | -65.0% | 1,000 | -75.0% | 0.00% | – |
| Q4 2020 | $60,000 | -4.8% | 4,000 | -20.0% | 0.00% | -100.0% |
| Q3 2020 | $63,000 | -26.7% | 5,000 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $86,000 | +30.3% | 5,000 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $66,000 | -54.5% | 5,000 | -44.4% | 0.00% | -50.0% |
| Q4 2019 | $145,000 | -12.1% | 9,000 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $165,000 | – | 9,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 2,204,449 | $10,824 | 1.35% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,233,000 | $6,054,030 | 1.14% |
| Chescapmanager LLC | 1,160,392 | $5,698 | 0.90% |
| DISCIPLINED GROWTH INVESTORS INC /MN | 1,732,375 | $8,505,961 | 0.22% |
| XTX Topco Ltd | 107,610 | $528,365 | 0.11% |
| IQ EQ FUND MANAGEMENT (IRELAND) Ltd | 84,530 | $415,042 | 0.08% |
| PINNACLE ASSOCIATES LTD | 679,413 | $3,335,918 | 0.07% |
| PDT Partners, LLC | 102,010 | $500,869 | 0.07% |
| FARALLON CAPITAL MANAGEMENT LLC | 1,995,370 | $9,797,267 | 0.05% |
| AXQ CAPITAL, LP | 27,760 | $136,302 | 0.05% |